Adaptation to Telehealth of Personalized Group Visits for Late Stage Diabetic Kidney Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P
. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47.
DOI: 10.1001/jama.298.17.2038.
View
2.
Sontakke S, Budania R, Bajait C, Jaiswal K, Pimpalkhute S
. Evaluation of adherence to therapy in patients of chronic kidney disease. Indian J Pharmacol. 2016; 47(6):668-71.
PMC: 4689023.
DOI: 10.4103/0253-7613.169597.
View
3.
Drake C, Lewinski A, Rader A, Schexnayder J, Bosworth H, Goldstein K
. Addressing Hypertension Outcomes Using Telehealth and Population Health Managers: Adaptations and Implementation Considerations. Curr Hypertens Rep. 2022; 24(8):267-284.
PMC: 9087161.
DOI: 10.1007/s11906-022-01193-6.
View
4.
Drake C, Lian T, Cameron B, Medynskaya K, Bosworth H, Shah K
. Understanding Telemedicine's "New Normal": Variations in Telemedicine Use by Specialty Line and Patient Demographics. Telemed J E Health. 2021; 28(1):51-59.
PMC: 8785715.
DOI: 10.1089/tmj.2021.0041.
View
5.
Go A, Chertow G, Fan D, McCulloch C, Hsu C
. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305.
DOI: 10.1056/NEJMoa041031.
View